BCAB BioAtla, Inc.

NASDAQ
$3.09

BioAtla, Inc. (BCAB) is expected to report earnings on November 12, 2026, after the market close.

BioAtla Reported Earnings
Thursday, August 13, 2026 · 12:00 AM ET
Earnings Date
Nov 12
Thursday · 4:05 PM ET
Earnings Whisper
-
vs -
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP -

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About BioAtla, Inc.

ioAtla is a global clinical-stage biotechnology company with operations in San Diego, California, and in Beijing, China through our contractual relationship with BioDuro-Sundia, a provider of preclinical development services.

Sector

Healthcare